Beacon MedTech names new president

NEWS RELEASE: Beacon MedTech Solutions Appoints New President

Industry Veteran Jim Colony Joins to Drive Strategic Growth Across High-Technology Markets

LEOMINSTER, Mass. (December 19, 2023) – Beacon MedTech Solutions is pleased to announce that James “Jim” Colony will serve as the company’s president, effective immediately. Bringing a track record of success in strategic planning and manufacturing management, Colony will be responsible for driving strategic growth, continued excellence in engineering and quality, and strengthened customer relationships across Medical, Life Sciences, Bio-Pharma, Aerospace, Defense and Technology markets.

Colony initially joined Beacon MedTech Solutions in an interim capacity in March 2023, becoming president in August following confirmation by Beacon Manufacturing Group’s Board of Directors. He is a veteran executive with more than 30 years of C-suite experience in operations and strategy, leadi…

Read more
  • 0

Three considerations for reshoring your medical device components and assemblies

Validation is a critical process to keep patients and end users safe. Proper documentation of tooling maintenance and repairs, adjustments to process and part design will help facilitate a successful and efficient validation process. [Photo courtesy of Beacon MedTech Solutions]

Reshoring medical devices — moving production back to the United States — requires strategic and complex navigation.

John Banks and Richard Landry, Beacon MedTech Solutions

Reshoring is a topic of conversation with almost every biopharma, life sciences and medical company currently outsourcing production of thermoplastic or silicone parts, products and assemblies to overseas molders.

Just look at the numbers. The Reshoring Initiative released data showing that reshoring and foreign direct investments are projected to drive an additional 350,000 U.S jobs in 2022, a record high.

The reasons for this growth are numerous. C…

Read more
  • 0